All changes for the tissue nervous system (640)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA1
abhydrolase domain containing 14A
Molecular
brain
Human
ABHD14A
3.0% Decrease Gene Expression Level
DAA10
KN motif and ankyrin repeat domains 1
Molecular
brain
Human
KANK1
16.0% Increase Gene Expression Level
DAA100
guanylate kinase 1
Molecular
brain
Human
GUK1
5.0% Decrease Gene Expression Level
DAA101
holocytochrome c synthase (cytochrome c heme-lyase)
Molecular
brain
Human
HCCS
14.0% Decrease Gene Expression Level
DAA102
histidine triad nucleotide binding protein 1
Molecular
brain
Human
HINT1
5.0% Decrease Gene Expression Level
DAA1026
Stroke (Male)
Pathological
brain
Human
—
SeriesIncidence
DAA1027
Stroke (Female)
Pathological
brain
Human
—
SeriesIncidence
DAA103
hepatic leukemia factor
Molecular
brain
Human
HLF
10.0% Decrease Gene Expression Level
DAA104
heat shock 70kDa protein 8
Molecular
brain
Human
HSPA8
7.0% Decrease Gene Expression Level
DAA105
heat shock protein 90kDa alpha (cytosolic), class B member 1
Molecular
brain
Human
HSP90AB1
5.0% Decrease Gene Expression Level
DAA1050
Mental Health (psychological distress) (Male)
Pathological
brain
Human
—
SeriesIncidence
DAA1051
Mental Health (psychological distress) (Female)
Pathological
brain
Human
—
SeriesIncidence
DAA106
HtrA serine peptidase 1
Molecular
brain
Human
HTRA1
7.0% Increase Gene Expression Level
DAA1065
efflux pump activity decreases
Molecular
blood brain barrier
Human
—
—
DAA1066
glucose transporter 1 activity decreases
Molecular
blood brain barrier
Human
SLC2A1
—
DAA1067
transporter activity decreases
Molecular
blood brain barrier
Human
—
—
DAA107
ring finger protein 19B
Molecular
brain
Human
RNF19B
11.0% Decrease Gene Expression Level
DAA1072
CYFIP2 A to I mRNA editing decreases
Molecular
frontal lobe
Human
CYFIP2
Increase mRNA Editing
DAA1075
Presbycusis
Pathological
cochlea
Human
—
—
DAA1076
Progressive liquefaction
Physiological
vitreous humor
Human
—
—
DAA1077
Pipecolic Acid Oxidase
Molecular
cerebellum
Human
PIPOX
Increase DNA Methylation
DAA1078
Pipecolic Acid Oxidase
Molecular
frontal lobe
Human
PIPOX
Increase DNA Methylation
DAA1079
Pipecolic Acid Oxidase
Molecular
pons
Human
PIPOX
Increase DNA Methylation
DAA108
inhibin, beta B
Molecular
brain
Human
INHBB
17.0% Increase Gene Expression Level
DAA1080
Pipecolic Acid Oxidase
Molecular
temporal lobe
Human
PIPOX
Increase DNA Methylation
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA1 | abhydrolase domain containing 14A | Molecular | brain | Human | ABHD14A | 3.0% Decrease Gene Expression Level | |
DAA10 | KN motif and ankyrin repeat domains 1 | Molecular | brain | Human | KANK1 | 16.0% Increase Gene Expression Level | |
DAA100 | guanylate kinase 1 | Molecular | brain | Human | GUK1 | 5.0% Decrease Gene Expression Level | |
DAA101 | holocytochrome c synthase (cytochrome c heme-lyase) | Molecular | brain | Human | HCCS | 14.0% Decrease Gene Expression Level | |
DAA102 | histidine triad nucleotide binding protein 1 | Molecular | brain | Human | HINT1 | 5.0% Decrease Gene Expression Level | |
DAA1026 | Stroke (Male) | Pathological | brain | Human | — | SeriesIncidence | |
DAA1027 | Stroke (Female) | Pathological | brain | Human | — | SeriesIncidence | |
DAA103 | hepatic leukemia factor | Molecular | brain | Human | HLF | 10.0% Decrease Gene Expression Level | |
DAA104 | heat shock 70kDa protein 8 | Molecular | brain | Human | HSPA8 | 7.0% Decrease Gene Expression Level | |
DAA105 | heat shock protein 90kDa alpha (cytosolic), class B member 1 | Molecular | brain | Human | HSP90AB1 | 5.0% Decrease Gene Expression Level | |
DAA1050 | Mental Health (psychological distress) (Male) | Pathological | brain | Human | — | SeriesIncidence | |
DAA1051 | Mental Health (psychological distress) (Female) | Pathological | brain | Human | — | SeriesIncidence | |
DAA106 | HtrA serine peptidase 1 | Molecular | brain | Human | HTRA1 | 7.0% Increase Gene Expression Level | |
DAA1065 | efflux pump activity decreases | Molecular | blood brain barrier | Human | — | — | |
DAA1066 | glucose transporter 1 activity decreases | Molecular | blood brain barrier | Human | SLC2A1 | — | |
DAA1067 | transporter activity decreases | Molecular | blood brain barrier | Human | — | — | |
DAA107 | ring finger protein 19B | Molecular | brain | Human | RNF19B | 11.0% Decrease Gene Expression Level | |
DAA1072 | CYFIP2 A to I mRNA editing decreases | Molecular | frontal lobe | Human | CYFIP2 | Increase mRNA Editing | |
DAA1075 | Presbycusis | Pathological | cochlea | Human | — | — | |
DAA1076 | Progressive liquefaction | Physiological | vitreous humor | Human | — | — | |
DAA1077 | Pipecolic Acid Oxidase | Molecular | cerebellum | Human | PIPOX | Increase DNA Methylation | |
DAA1078 | Pipecolic Acid Oxidase | Molecular | frontal lobe | Human | PIPOX | Increase DNA Methylation | |
DAA1079 | Pipecolic Acid Oxidase | Molecular | pons | Human | PIPOX | Increase DNA Methylation | |
DAA108 | inhibin, beta B | Molecular | brain | Human | INHBB | 17.0% Increase Gene Expression Level | |
DAA1080 | Pipecolic Acid Oxidase | Molecular | temporal lobe | Human | PIPOX | Increase DNA Methylation |